富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
10.82美元0.04(0.37%)
2023/06/06更新
績效 / 1月3.06%
3月1.89%
1年14.8%
晨星評等-
- 1.現金3.52%
- 2.股票13.31%
- 3.債券0.00%
- 4.其他83.17%
- 1.美國82.99%
- 2.英國5.58%
- 3.歐洲不包含歐元區3.56%
- 4.新興亞洲2.58%
- 5.歐元區1.33%
- 1.Vertex Pharmaceuticals Inc7.11%
- 2.Amgen Inc6.50%
- 3.Regeneron Pharmaceuticals Inc6.48%
- 4.Gilead Sciences Inc5.68%
- 5.AstraZeneca PLC ADR4.90%
- 6.Biogen Inc4.39%
- 7.Jazz Pharmaceuticals PLC4.36%
- 8.PTC Therapeutics Inc4.22%
- 9.Federal Home Loan Banks 0%3.51%
- 10.Intra-Cellular Therapies Inc3.28%
- 1.現金3.52%
- 2.股票13.31%
- 3.債券0.00%
- 4.其他83.17%
- 1.美國82.99%
- 2.英國5.58%
- 3.歐洲不包含歐元區3.56%
- 4.新興亞洲2.58%
- 5.歐元區1.33%
- 1.Vertex Pharmaceuticals Inc7.11%
- 2.Amgen Inc6.50%
- 3.Regeneron Pharmaceuticals Inc6.48%
- 4.Gilead Sciences Inc5.68%
- 5.AstraZeneca PLC ADR4.90%
- 6.Biogen Inc4.39%
- 7.Jazz Pharmaceuticals PLC4.36%
- 8.PTC Therapeutics Inc4.22%
- 9.Federal Home Loan Banks 0%3.51%
- 10.Intra-Cellular Therapies Inc3.28%